Resmed (RMD) Asset Writedowns and Impairment (2009 - 2021)

Resmed (RMD) has 11 years of Asset Writedowns and Impairment data on file, last reported at -$5.1 million in Q2 2021.

• Quarterly Asset Writedowns and Impairment changed N/A year-over-year to -$5.1 million in Q2 2021, while the trailing twelve-month figure through Jun 2021 was -$14.5 million (down 199.97% YoY) and the FY2023 annual result came in at -$9.9 million, down 181.31% from the prior year.
• Asset Writedowns and Impairment fell to -$5.1 million in Q2 2021, from -$4.7 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $9.1 million in Q1 2020 to a low of -$8.5 million in Q3 2020.
• A 5-year average of $1.7 million and a median of $1.4 million in 2017 frame the typical range for Asset Writedowns and Impairment.
• Annual changes were most pronounced in 2018 — Asset Writedowns and Impairment soared 483.25% — and 2020, when it slumped 426.0%.
• Tracing RMD's Asset Writedowns and Impairment over 5 years: stood at $1.3 million in 2017, then slipped by 3.41% to $1.2 million in 2018, then jumped by 125.88% to $2.8 million in 2019, then surged by 31.25% to $3.7 million in 2020, then slumped by 237.11% to -$5.1 million in 2021.
• The last three Asset Writedowns and Impairment figures came in at -$5.1 million (Q2 2021), -$4.7 million (Q1 2021), and $3.7 million (Q4 2020), per Business Quant data.